Andrey Semechkin
Fortuna: 2 M $ al 31/08/2026
Fortuna: 2 M $ al 31/08/2026
Dr. Andrey Semechkin is a Co-Chairman & Chief Executive Officer at International Stem Cell Corp.
and a Member at Russian Academy of Sciences.
Dr. Semechkin was previously employed as a Chief Executive Officer by X-Master, Inc. and a Deputy Director by Institute For System Analysis.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 10/07/2026 | 4.212.992 ( 52,63 % ) | 2 M $ | 31/08/2026 | |
| 10/07/2026 | 499.270 ( 9,99 % ) | 190 721 $ | 31/08/2026 | |
| 10/07/2026 | 4.310 ( 100 % ) | 1 646 $ | 31/08/2026 | |
| 10/07/2026 | 33 ( 76,74 % ) | 13 $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| INTERNATIONAL STEM CELL CORPORATION | Director Ejecutivo | 01/11/2009 |
Russian Academy of Sciences
Russian Academy of Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/04/2010 |
| Empresas | Cargo | Fin |
|---|---|---|
Institute For System Analysis | Corporate Officer/Principal | 01/01/2011 |
X-Master, Inc. | Presidente | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
Moscow State University
Moscow State University Other Consumer ServicesConsumer Services College/University | Consumer Services |
Russian Academy of Sciences
Russian Academy of Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
International Stem Cell Corp.
International Stem Cell Corp. Medical SpecialtiesHealth Technology Operates as a biotechnology company, which focused on therapeutic and biomedical product development with multiple long-term therapeutic opportunities | Health Technology |
X-Master, Inc. | |
Institute For System Analysis |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.